Stephen Bush, MD
Obstetrics & Gynecology · Charleston, WVNPI 1013980416
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Applied Medical Resources Corporation accounts for 72.3% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2021 at $12,668 and has fallen 59.1% since, to $5,176 in 2025. Among obstetrics & gynecology clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 162 payments — averaging $206.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Applied Medical Resources Corporation$24K
- Intuitive Surgical$5K
- Johnson & Johnson$2K
- GSK$606
- Pfizer$303
- Mayne Pharma Commercial LLC$284
- plus $2K from 25 others
Across 2 payments — averaging $8692.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$17K
What the payments were for
- Speaking & faculty fees$18,00054%
- Travel & lodging$5,34516%
- Food & beverage$5,58817%
- Education$4,48913%
- Gifts$420%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Applied Medical Resources Corporation | 25 | $24,187 |
| Intuitive Surgical | 12 | $4,523 |
| Johnson & Johnson | 25 | $1,730 |
| GSK | 6 | $606 |
| Pfizer | 20 | $303 |
| Mayne Pharma Commercial LLC | 1 | $284 |
| AbbVie(2 entities) | 15 | $280 |
| Sumitomo Pharma America, Inc. | 11 | $203 |
| Medical Device Business Services, Inc. | 1 | $137 |
| Eisai Inc. | 3 | $130 |
| Pacira Pharmaceuticals Incorporated | 1 | $125 |
| AstraZeneca | 1 | $120 |
| AMAG Pharmaceuticals, Inc. | 8 | $119 |
| Lupin Inc. | 1 | $92 |
| Therapeuticsmd, Inc. | 6 | $88 |
| Astellas Pharma US Inc | 5 | $75 |
| Immunogen, Inc. | 3 | $71 |
| Boston Scientific | 2 | $65 |
| Sage Therapeutics, LLC | 2 | $58 |
| Bayer | 2 | $58 |
| Merck | 2 | $31 |
| Coopersurgical, Inc. | 1 | $27 |
| Conmed Corporation | 1 | $24 |
| Fennec Pharmaceuticals, Inc. | 1 | $21 |
| Baxter Healthcare | 1 | $19 |
| Mallinckrodt Enterprises LLC | 1 | $17 |
| Myovant Sciences Inc. | 1 | $16 |
| Medtronic | 1 | $16 |
| Acessa Health Inc. | 1 | $14 |
| Avion Pharmaceuticals | 1 | $14 |
| Meditrina | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GelPOINT V-Path$32,583
- Da Vinci Surgical System$4,234
- GELPOINT VPATH$1,121
- VISTASEAL$488
- STRATAFIX$477
- ZEJULA$455
- Enseal X1$260
- Enseal$248
- Harmonic$248
- EXPAREL$125
- Echelon Circular$122
- HARMONIC Product Family$118
How this compares
$33,464 in reported general payments places this provider in the 95th percentile of 172 obstetrics & gynecology providers in West Virginia.
See all obstetrics & gynecology providers in West Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 16 | $11,137 |
| Estradiol | 38 | $1,151 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $75 | $11,13716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 172 obstetrics & gynecology providers in West Virginia.
Other obstetrics & gynecology in Charleston
- Paul DietzCharleston$14K
- David PattonCharleston$12K
- Scott NaegeleCharleston$8K
- Michael LaoCharleston$7K
- David ThomasCharleston$7K
- Paul HunterCharleston$6K
- Dara AliffCharleston$3K
- Karinna AndrewsCharleston$3K
- Megan HarrisonCharleston$2K
- Michaela KesslerCharleston$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.